Tenon Medical (TNON) Common Equity (2021 - 2026)

Tenon Medical has reported Common Equity for 6 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 79.79% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 79.79% YoY), and the FY2025 full-year result was $5.0 million, down 15.59% from the prior year.
• Common Equity for Q1 2026 stood at $1.9 million, down from $5.0 million in the prior quarter.
• The five-year high for Common Equity was $15.1 million in Q2 2022, with the low at -$22.7 million in Q1 2022.
• Average Common Equity over 5 years is $3.8 million, with a median of $4.8 million recorded in 2025.
• Year-over-year, Common Equity plunged 682.38% in 2022 and surged 706.85% in 2025.
• Tracing TNON's Common Equity over 5 years: stood at $6.3 million in 2022, then sank by 87.56% to $778000.0 in 2023, then surged by 667.48% to $6.0 million in 2024, then dropped by 15.59% to $5.0 million in 2025, then tumbled by 62.4% to $1.9 million in 2026.
• The last three Common Equity figures came in at $1.9 million (Q1 2026), $5.0 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.

Peer Comparison